World Health Organization Issues Concern Over Severe Lack of Weight-Loss Medications

Less than 10% of people that would benefit from GLP-1 drugs such as Wegovy can access them, warns the World Health Organization as it issues its inaugural advice on the drugs.

With over a billion individuals worldwide now classified as obese, it is advocating for broader and more equitable access to this class of drugs.

Based on forecasts, in excess of 2,000,000,000 will be obese by 2030 if no action is taken.

"The new guidelines acknowledges that obesity is a chronic disease that can be managed with holistic and continuous treatment," said WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and supply-chain constraints are significant obstacles to universal availability to the injections that can assist patients in reducing significant body mass, explains the body.

Weight-Loss Drug Scarcity

Despite the present best projected outlook, the supply of GLP-1 therapies would only suffice for around 100 million people – under 10% of the global need, as stated by the health organization.

The recommendation calls on governments and firms to increase access, by approaches including patent sharing.

The intellectual property rights on a key compound – the core ingredient of a leading brand – is due to expire in several countries in 2026.

How Obesity Jabs Function

GLP-1 drugs mimick a body's own hormone to reduce digestion speed, suppress the appetite and enhance feelings of fullness so individuals reduce food intake.

Individuals commonly start to lose weight in the initial weeks of commencing the once-weekly jabs.

Studies suggests people may see weight return a year later of stopping the medication, when their usual appetite return.

To be overweight or obese elevates your likelihood for developing medical conditions, including diabetes, cardiovascular issues, brain attack, and certain malignancies.

Obesity impacts people in all nations and was responsible for over three and a half million fatalities worldwide in 2024, according to the WHO.